EU
Emory University Portfolio holdings
AUM
$27.7M
This Quarter Return
+8.08%
1 Year Return
+31.53%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$140M
AUM Growth
+$140M
(+20%)
Cap. Flow
+$20.1M
Cap. Flow
% of AUM
14.33%
Top 10 Holdings %
Top 10 Hldgs %
45.63%
Holding
53
New
9
Increased
27
Reduced
8
Closed
7
Top Buys
| 1 |
BPMC
Blueprint Medicines
BPMC
|
$2.95M |
| 2 |
ABLX
Ablynx NV American Depositary Shares
ABLX
|
$2.63M |
| 3 |
InflaRx
IFRX
|
$2.62M |
| 4 |
SAGE
Sage Therapeutics
SAGE
|
$2.6M |
| 5 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$2.44M |
Top Sells
| 1 |
BioCryst Pharmaceuticals
BCRX
|
$1.88M |
| 2 |
Baker Hughes
BKR
|
$1.87M |
| 3 |
AAAP
Advanced Accelerator Applications S.A. American Depositary Shares
AAAP
|
$1.84M |
| 4 |
TSRO
TESARO, Inc.
TSRO
|
$1.69M |
| 5 |
AVEO
AVEO Pharmaceuticals, Inc.
AVEO
|
$1.68M |
Sector Composition
| 1 | Healthcare | 53.45% |
| 2 | Financials | 29.17% |
| 3 | Consumer Discretionary | 3.76% |
| 4 | Technology | 3.25% |
| 5 | Industrials | 2.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Berkshire Hathaway Class A
BRK.A
$1.09T
| $35M | 24.99% | 117 | – | – |
|
2
JD.com
JD
$44.1B
| $5.04M | 3.6% | 124,490 +50 | +0% | +$2.03K |
|
|
MYOV
3
DELISTED
Myovant Sciences Ltd.
MYOV
| $3.75M | 2.68% | 176,387 +45,024 | +34% | +$958K |
|
|
ONC
4
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $3.22M | 2.3% | 19,170 -2,786 | -13% | -$468K |
|
5
Ascendis Pharma
ASND
$11.8B
| $3.07M | 2.19% | 46,933 -3,880 | -8% | -$254K |
|
|
BPMC
6
DELISTED
Blueprint Medicines
BPMC
| $2.95M | 2.11% | +32,163 | New | +$2.95M |
|
7
KALA BIO
KALA
$78.8M
| $2.81M | 2% | 177,342 +78,546 | +80% | +$1.24M |
|
|
AVXS
8
DELISTED
AveXis, Inc. Common Stock
AVXS
| $2.78M | 1.98% | 22,474 +4,000 | +22% | +$494K |
|
9
Puma Biotechnology
PBYI
$254M
| $2.66M | 1.9% | 39,066 +22,022 | +129% | +$1.5M |
|
|
ABLX
10
DELISTED
Ablynx NV American Depositary Shares
ABLX
| $2.63M | 1.88% | +48,194 | New | +$2.63M |
|
|
11
InflaRx
IFRX
$108M
| $2.62M | 1.87% | +90,761 | New | +$2.62M |
|
|
SAGE
12
DELISTED
Sage Therapeutics
SAGE
| $2.6M | 1.86% | +16,132 | New | +$2.6M |
|
13
Amicus Therapeutics
FOLD
$2.34B
| $2.6M | 1.85% | 172,666 +37,302 | +28% | +$561K |
|
14
Travere Therapeutics
TVTX
$1.56B
| $2.57M | 1.84% | 115,136 +30,251 | +36% | +$676K |
|
15
Neurocrine Biosciences
NBIX
$13.8B
| $2.55M | 1.82% | 30,725 +5,780 | +23% | +$479K |
|
|
ZGNX
16
DELISTED
Zogenix, Inc.
ZGNX
| $2.54M | 1.82% | 63,499 +14,656 | +30% | +$587K |
|
17
Alnylam Pharmaceuticals
ALNY
$58.5B
| $2.54M | 1.81% | 21,316 +6,972 | +49% | +$830K |
|
18
Incyte
INCY
$16.5B
| $2.54M | 1.81% | 30,447 +13,401 | +79% | +$1.12M |
|
19
Neurogene
NGNE
$264M
| $2.52M | 1.8% | 179,162 +8,758 | +5% | +$123K |
|
|
SGEN
20
DELISTED
Seagen Inc. Common Stock
SGEN
| $2.52M | 1.8% | 48,079 +16,396 | +52% | +$858K |
|
21
BioMarin Pharmaceuticals
BMRN
$11.2B
| $2.5M | 1.78% | 30,823 +8,686 | +39% | +$704K |
|
|
GHDX
22
DELISTED
Genomic Health, Inc.
GHDX
| $2.49M | 1.78% | 79,591 +16,665 | +26% | +$521K |
|
|
XLRN
23
DELISTED
Acceleron Pharma Inc.
XLRN
| $2.44M | 1.74% | +62,410 | New | +$2.44M |
|
|
ALXN
24
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $2.43M | 1.73% | 21,793 +5,020 | +30% | +$560K |
|
|
CORI
25
DELISTED
Corium International, Inc.
CORI
| $2.42M | 1.72% | 210,559 +42,506 | +25% | +$488K |
|